Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2026)

Solid Biosciences has disclosed Interest & Investment Income across 10 years of filings, most recently posting $2.1 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.1 million, down 10.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.7 million (up 6.03% YoY), and the FY2025 annual result was $9.9 million, up 4.59% from the prior year.
• Interest & Investment Income came in at $2.1 million for Q1 2026 at Solid Biosciences, up from $2.1 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q2 2025 to a low of $54000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $2.1 million (2025), against an average of $1.9 million.
• Across the five-year window, Interest & Investment Income jumped 3231.48% in 2023 and dropped 13.24% in 2025, its largest moves.
• Solid Biosciences' Interest & Investment Income stood at $1.5 million in 2022, then grew by 14.73% to $1.8 million in 2023, then climbed by 9.38% to $1.9 million in 2024, then rose by 6.6% to $2.1 million in 2025, then advanced by 0.58% to $2.1 million in 2026.
• The last three Interest & Investment Income figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.